1jsp image
Deposition Date 2001-08-17
Release Date 2002-08-17
Last Version Date 2024-10-16
Entry Detail
PDB ID:
1JSP
Title:
NMR Structure of CBP Bromodomain in complex with p53 peptide
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
200
Conformers Submitted:
20
Selection Criteria:
structures with the least restraint violations,structures with the lowest energy
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:tumor protein p53
Gene (Uniprot):TP53
Chain IDs:A
Chain Length:20
Number of Molecules:1
Biological Source:
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:CREB-BINDING PROTEIN
Gene (Uniprot):CREBBP
Chain IDs:B
Chain Length:121
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ALY A LYS N(6)-ACETYLLYSINE
Ligand Molecules
Primary Citation
Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation.
Mol.Cell 13 251 263 (2004)
PMID: 14759370 DOI: 10.1016/S1097-2765(03)00528-8

Abstact

Lysine acetylation of the tumor suppressor protein p53 in response to a wide variety of cellular stress signals is required for its activation as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis. Here, we report that the conserved bromo-domain of the transcriptional coactivator CBP (CREB binding protein) binds specifically to p53 at the C-terminal acetylated lysine 382. This bromodomain/acetyl-lysine binding is responsible for p53 acetylation-dependent coactivator recruitment after DNA damage, a step essential for p53-induced transcriptional activation of the cyclin-dependent kinase inhibitor p21 in G1 cell cycle arrest. We further present the three-dimensional nuclear magnetic resonance structure of the CBP bromodomain in complex with a lysine 382-acetylated p53 peptide. Using structural and biochemical analyses, we define the molecular determinants for the specificity of this molecular recognition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback